References
Boyle P, Levin B, editors. World Cancer Report 2008. Lyon: International Agency for Research on Cancer (IARC); 2008.
Smith RA, Caleffi M, Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006;12(Suppl 1):S16–26. doi:10.1111/j.1075-122X.2006.00200.x.
Ifere GO, Abebe F, Ananaba GA. Emergent trends in the reported incidence of prostate cancer in Nigeria. Clin Epidemiol. 2012;4:19–32. doi:10.2147/CLEP.S23536.
Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010;376(9747):1186–93. doi:10.1016/S0140-6736(10)61152-X.
Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203–10. doi:10.1056/NEJMoa1000727.
Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ. 2010;340:c1241.
Gotzsche PC, Jorgensen KJ, Zahl PH, Maehlen J. Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control. 2012;23(1):15–21. doi:10.1007/s10552-011-9867-8.
Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605–13. doi:10.1093/jnci/djq099.
Adami HO. The prostate cancer pseudo-epidemic. Acta Oncol. 2010;49(3):298–304. doi:10.3109/02841860903584945.
Loeb S, Vonesh EF, Metter EJ, Carter HB, Gann PH, Catalona WJ. What is the true number needed to screen and treat to save a life with prostate-specific antigen testing? J Clin Oncol. 2011;29(4):464–7. doi:10.1200/JCO.2010.30.6373.
Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann intern med. 2011;155(11):762–71. doi:10.1059/0003-4819-155-11-201112060-00375.
Prorok PC, Andriole GL, Bresalier RS, et al. Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials. 2000;21(6 Suppl):273S–309S.
Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993;328(19):1365–71. doi:10.1056/NEJM199305133281901.
Bretthauer M, Kalager M. Colonoscopy as a triage screening test. N Engl J Med. 2012;366(8):759–60. doi:10.1056/NEJMe1114639.
Clarke EA, Anderson TW. Does screening by “Pap” smears help prevent cervical cancer? A case-control study. Lancet. 1979;2(8132):1–4.
Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control. 1997;8(5):755–63.
Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366(9499):1784–93.
Beaglehole R, Bonita R, Horton R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47.
Chokshi DA, Farley TA. The cost-effectiveness of environmental approaches to disease prevention. N Engl J Med. 2012;367(4):295–7. doi:10.1056/NEJMp1206268.
Whitby LG. Screening for disease: definitions and criteria. Lancet. 1974;2(7884):819–22.
Ponten J, Adami HO, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer. 1995;60(1):1–26.
Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;. doi:10.1002/cncr.27410.
Acknowledgments
We thank Dr Michelle Holmes at Harvard School of Public Health, Harvard University, and Dr Jacob Holmqvist, at Karlstad Central Hospital, Karlstad, Sweden for their comments on an earlier draft of this report. No specific funding was acquired, but Dr Gustaf Edgren is supported by a postdoctoral grant from Svenska Sällskapet för Medicinsk Forskning (SSMF).
Conflict of interest
We declare we have no relevant conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Edgren, G., Lagiou, P., Trichopoulos, D. et al. Screening, case finding or primary cancer prevention in the developing world?. Eur J Epidemiol 28, 287–290 (2013). https://doi.org/10.1007/s10654-013-9788-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-013-9788-9